Oncogene EiC Justin Stebbing, a hypocrite of research integrity?

Oncogene EiC Justin Stebbing, a hypocrite of research integrity?

The cancer research journal Oncogene issued on October 16th 2017 an Editorial on the topic of research integrity:

“The importance of being earnest in post-publication review: scientific fraud and the scourges of anonymity and excuses”.

The editorial contains a list of 8 common excuses dishonest authors used to escape responsibility for manipulated data. It was authored by David Sanders, virologist and professor at the Department of Biological Sciences at the Purdue University in West Lafayette, Indiana, US, as well as Justin Stebbing, professor of cancer medicine and oncology at the Imperial College London, UK, who is also one of the two Editors-in-Chief (EiC) of the journal Oncogene. Sander is one of these rare brave academics who is unafraid to call out scientific misconduct while his peers hide in the bushes and instead even point fingers at whistleblowers like him. As the newspaper USA Today wrote earlier this year, Sanders made himself a very powerful enemy, the star US cancer researcher with Italian origins, Carlo Croce:

“But that didn’t stop Sanders from alleging that Dr. Carlo Croce, a prominent cancer researcher at Ohio State University, falsified data or plagiarized text in more than two dozen articles Croce has authored. For the past two-plus years, Sanders has contacted scientific journals in which the articles appeared to alert them of his concerns. Earlier this month, he went more public with his claims in an investigative piece by the New York Times that delved into years of ethics charges against Croce.

“There are, and I anticipate there will be additional, consequences for my career,” Sanders said Tuesday afternoon while sitting in his office inside the Hockmeyer Hall of Structural Biology at Purdue.

This isn’t the first time Sanders has publicly accused a scientist of bad behavior. In 2012, Sanders had an article by a former colleague retracted on the basis that the colleague used their former deceased research partner’s data in the paper without permission”.

A long article appeared in The New York Times prior to that, “Years of Ethics Charges, but Star Cancer Researcher Gets a Pass“, detailing the case of Carlo Croce and the role of Sanders the whistleblower, and the Ohio State University, who were mostly covering up the affair. Croce hit back: he is now suing the newspaper, and in separate lawsuit, also Sanders at a New York court, as reported by Retraction Watch.

Hence, Sanders knows first-hand what research misconduct is and how to act upon it. Indeed, the editorial was his idea, and his co-author Stebbing joined afterwards. As Sanders wrote to me:

“The impulse for the editorial and the list was from me.  We discussed the inclusion of particular items and how they were described together”.

Stebbing indeed is not much of a whistleblower, quite the opposite, he can be in fact seen as victim of such. His own publication was heavily criticised on PubPeer, for suspected western blot band duplications. And the piquant bit is: Stebbings, together with his first author  Georgios Giamas (now Reader in Biochemistry at the University of Sussex, UK) offered on PubPeer explanations which sound very much as what he himself has been ridiculing in the Sanders & Stebbing editorial in his journal Oncogene. Continue reading “Oncogene EiC Justin Stebbing, a hypocrite of research integrity?”

Voinnet’s sidekick Dunoyer welcomed at Nature Plants, despite retractions and admitted misconduct

Voinnet’s sidekick Dunoyer welcomed at Nature Plants, despite retractions and admitted misconduct

The Olivier Voinnet scandal of almost two decades-long research misconduct and data manipulations has reached its logical conclusion. The French plant pathogen researcher, and everyone who helped him manipulating and publishing dishonest (and occasionally retracted) papers was either forgiven or declared as fully reformed. The siRNA-co-discoverer Voinnet who, cynically put, was too big to fail, remained professor at ETH Zürich and kept his ERC funding. He is meanwhile back to publishing in exactly the same elite journals where he had to retract and correct papers for manipulations. Of all his “partners-in-crime”, only his dependent right-hand man (or sidekick) Patrice Dunoyer was ever investigated, and as punishment suspended for an entire month by his French employer CNRS. His lab was about to be dissolved, but the Nature Publishing Group came to rescue and accepted his paper (Incarbone et al 2017) just in the nick of time (it’s not even Dunoyer’s only recent publishing success, another one is Montavon et al 2017 in Nucleic Acids Research). The accompanying editorial in Nature Plants, written by the chief editor Chris Surridge can only be described as bizarre, and is titled: “Giving research a sporting chance“. Surridge, who apparently sees data manipulation as a professional sports in race with doping detectives, wrote:

“Dunoyer has been a long-time colleague and collaborator of Olivier Voinnert, and recently a number of their studies, three with Dunoyer as first author, have been retracted while a number more have had formal corrections published to address problems with presented data. However, these instances were investigated by the CNRS and Dunoyer served a temporary suspension as a result. We therefore treated the study we received as we would any other. It was accepted following two rounds of review, during which it was seen by four reviewers. The published paper contains substantial supplementary information (SI). Along with 10 additional figures, there are a further 12 pages presenting the raw data from which the presented figures have been assembled”.

Continue reading “Voinnet’s sidekick Dunoyer welcomed at Nature Plants, despite retractions and admitted misconduct”

Updated: Retraction, and another looming misconduct finding for Macchiarini and Jungebluth

Updated: Retraction, and another looming misconduct finding for Macchiarini and Jungebluth

The misconduct-tainted paper on oesophagus transplants in rats (Sjöqvist et al 2014) by the fallen star of regenerative medicine Paolo Macchiarini is finally retracted by the journal Nature Communications. This happens after Swedish investigations found the authors (primarily the scandal thorax surgeon and his right-hand man Philipp Jungebluth) guilty of data manipulation and research misconduct in September 2016 and after the Karolinska Institutet (KI) shortly before Christmas publicly demanded a retraction (see my report here). Today’s retraction is a major setback for Macchiarini, since his current employment and funding at the Federal University of Kazan (KFU) in Russia depend on his experiments with oesophageal transplants in primates (see my reports here and here). That Russian project was in turn only possible because of Macchiarini’s allegedly successful experiments in rats, published in a prestige journal with “Nature” in its title. This paper’s retraction is therefore probably only the beginning of a whole looming avalanche of bad news for Macchiarini and his acolyte Jungebluth (who currently sues me in court). An expert review of their publication Jungebluth et al 2015 declares the findings of misconduct, ethics breach and patient abuse. The report however has yet to be confirmed by a commission at the Swedish Central Ethics Review Board (CEPN) and then formulated as an official decree by the KI. I publish the expert reviewer report below. Continue reading “Updated: Retraction, and another looming misconduct finding for Macchiarini and Jungebluth”

Three retractions and lost court case for zombie Susana Gonzalez

Three retractions and lost court case for zombie Susana Gonzalez

The Spanish zombie scientist Susana González, former star of regenerative medicine and ageing research, now retracts two papers in Nature Communications, after she only recently retracted a paper in Cell Cycle. The responsibility for the absence of original data and data manipulations is with her. She also recently lost her court case against her sacking with the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid, though this may go into the next court instance.  Her ERC research grant of €2 Million remains suspended. I previously reported about this and Gonzalez’s data integrity issues as well as her sacking from CNIC, and later on about her new job with Centro de Biología Molecular Severo Ochoa (CBMSO), also in Madrid. It seems at the present stage, Gonzalez is out on her ear of doing research, but certainly not out of being employed in academic research in Spain.  Continue reading “Three retractions and lost court case for zombie Susana Gonzalez”

Conspiracy Theory: Is NPG being assimilated by Frontiers???

The post below is a satiric parody, though the general facts and the document I publish are real and true.

On Monday, the 13th of June, Nature Publishing Group (NPG) journals shut down. Instead of high-impact papers, all the bedazzled scientific community could see was: Internal Server Error (500).

The website collapse was first noticed with the NPG journal Scientific Reports, but then spread upwards the impact factor scale to Nature Communications and even Nature itself.

What happened? The NatureNews team, begged to give any insights, remained suspiciously silent. No announcements were made, questions remained unanswered. Continue reading “Conspiracy Theory: Is NPG being assimilated by Frontiers???”